Nonrecurring Expenses Fund
Schedules
TAFS: 075-0125 /X - Nonrecurring Expenses Fund
| Line # | Split | Description | Iteration 2 Previously Approved Amount | Iteration 3 OMB Action Amount | Footnotes |
|---|---|---|---|---|---|
| 1000 | DA1 | Discretionary Actual - Unob Bal: Brought forward from 75-X-0125, October 1 | $1,189,424,661 | $1,189,424,661 | |
| 1000 | DE2 | Discretionary expected - Unob Bal: Brought forward from 75-75-X-0125.005 (CMS), October 1 | $0 | Line removed— | |
| 1000 | DA2 | Discretionary Actual - Unob Bal: Brought forward from 75-75-X-0125.005 (CMS), October 1 | $646,007 | $646,007 | |
| 1000 | DE5 | Discretionary expected - Unob Bal: Brought forward from 75-75-X-0125.006 (FDA), Oct | $0 | Line removed— | |
| 1000 | DA3 | Discretionary Actual - Unob Bal: Brought forward from 75-75-X-0125.009 (CDC), October 1 | $151,696,413 | $151,696,413 | |
| 1000 | DE6 | Discretionary expected - Unob Bal: Brought forward from 75-75-X-0125.008 (NIH), Oct 1 | $0 | Line removed— | |
| 1000 | DA4 | Discretionary Actual - Unob Bal: Brought forward from 75-75-X-0125.010 (IHS), Oct 1 | $92,743,783 | $92,743,783 | |
| 1000 | DE3 | Discretionary expected - Unob Bal: Brought forward from 75-75-X-0125.009 (CDC), October 1 | $0 | Line removed— | |
| 1000 | DA5 | Discretionary Actual - Unob Bal: Brought forward from 75-75-X-0125.006 (FDA), Oct | $10,552,488 | $10,552,488 | |
| 1000 | DE4 | Discretionary expected - Unob Bal: Brought forward from 75-75-X-0125.010 (IHS), Oct 1 | $0 | Line removed— | |
| 1000 | DA6 | Discretionary Actual - Unob Bal: Brought forward from 75-75-X-0125.008 (NIH), Oct 1 | $12,353,237 | $12,353,237 | |
| 1000 | DE1 | Discretionary expected - Unob Bal: Brought forward from 75-X-0125, October 1 | $0 | Line removed— | |
| 1010 | 1 | Unob Bal: Actual nonexpenditure transfers from 75-X-0125 | Line added— | -$571,600,000 -$571,600,000 | |
| 1010 | 2 | Unob Bal: antic nonexpenditure transfers from 75-X-0125 | Line added— | $0 | |
| 1011 | 1 | Unob Bal: Actual Transferred to other accounts 75-75-X-0125.009 (CDC) | $81,200,000 | $81,200,000 | |
| 1011 | 2 | Unob Bal: Actual Transferred to other accounts 75-75-X-0125.006 (FDA) | $425,400,000 | $425,400,000 | |
| 1011 | 3 | Unob Bal: Actual Transferred to other accounts 75-75-X-0125.008 (NIH) | $65,000,000 | $65,000,000 | |
| 1011 | 4 | Unob Bal: Antic Transferred to other accounts 75-75-X-0125.006 (FDA) | Line added— | $0 | |
| 1011 | 5 | Unob Bal: Antic Transferred to other accounts 75-75-X-0125.008 (NIH) | Line added— | $0 | |
| 1010 | Unob Bal: antic nonexpenditure transfers from 75-X-0125 | -$571,600,000 | +$571,600,000 Line removed— | ||
| 1011 | 6 | Unob Bal: Antic Transferred to other accounts 75-75-X-0125.009 (CDC) | Line added— | $0 | |
| 1021 | 1 | Unob Bal: Recov of prior year unpaid obligations 75-X-0125 | Line added— | +$4,750,000 $4,750,000 | |
| 1920 | Total budgetary resources avail (disc. and mand.) | $1,457,416,589 | +$4,750,000 $1,462,166,589 | ||
| 6018 | Nonrecurring Expenses Fund Projects | $494,676,171 | +$21,895,000 $516,571,171 | ||
| 6019 | NIH B&F | $432,294,882 | $432,294,882 | ||
| 6020 | CDC Chamblee Campus | $25,008,866 | $25,008,866 | ||
| 6170 | 1 | Apportioned in FY 2023 and future fiscal years | $505,436,670 | -$17,145,000 $488,291,670 | |
| 6190 | Total budgetary resources available | $1,457,416,589 | +$4,750,000 $1,462,166,589 | See footnotes below | |
| Footnotes for line 6190 (Previous): | A1: Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. A2: $317,927,118 in carryover and recoveries available for projects that were approved in prior fiscal years. A3: In addition to the amounts apportioned above, a $375,000,000 rescission enacted in PL 116-260 and extended in PL 117-043 is automatically precluded from obligation from this account via OMB CR 21-05. | ||||
| Footnotes for line 6190 (Current): | A1: Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. A2: $322,677,118 in carryover and recoveries available for projects that were approved in prior fiscal years. A3: In addition to the amounts apportioned above, a $375,000,000 rescission enacted in PL 116-260 and extended in PL 117-043 is automatically precluded from obligation from this account via OMB CR 21-05. | ||||
| 6170 | 2 | Apportioned in FY 2023and future fiscal years, NIH Buildings and Facilities | $0 | Line removed— | |
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. |
| A2 | $322,677,118 in carryover and recoveries available for projects that were approved in prior fiscal years. |
| A3 | In addition to the amounts apportioned above, a $375,000,000 rescission enacted in PL 116-260 and extended in PL 117-043 is automatically precluded from obligation from this account via OMB CR 21-05. |
The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.
| Number | Text |
|---|---|
| A1 | Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. |
| A2 | $317,927,118 in carryover and recoveries available for projects that were approved in prior fiscal years. |
| A3 | In addition to the amounts apportioned above, a $375,000,000 rescission enacted in PL 116-260 and extended in PL 117-043 is automatically precluded from obligation from this account via OMB CR 21-05. |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.